See analyst estimates and all valuation multiples for Pharma Diagnostics & Analytics
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $10.0B | n/a | n/a | |
| $8.3B | 6.8x | 19.4x | |
| $1.9B | 8.5x | -37.8x | |
| $1.7B | 5.9x | -12.5x | |
| $1.0B | n/a | n/a | |
| $344M | n/a | n/a | |
| $303M | 6969.6x | -8.9x | |
| $166M | 9.1x | 11.9x | |
| $153M | 3.0x | 18.2x | |
| $77.5M | 26.9x | -4.4x | |
| $44.8M | 2.6x | 13.6x | |
| $40.9M | 54.1x | -13.3x | |
| $24.1M | 10.0x | -4.9x | |
| $23.8M | 25.4x | -6.8x | |
| $20.0M | 0.7x | n/a | |
| $4.1M | n/a | n/a | |
| -$28.7M | n/a | 0.4x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Pharma Diagnostics & Analytics